The United Laboratories International Holdings Limited
(Incorporated in the Cayman Islands with limited liability)

Press Releases       

2009-December-13	TUL Obtained Products Approval for Recombinant Human Insulin Product, Full Sights on the Multi-billion Market (in PDF)
2009-November-13	TUL Obtained Products Approval for Two New Eye Drops Products (in PDF)
2009-November-10	TUL Acquired FDA Approval for its Product, Planned to Enter US Market (in PDF)
2009-September-9	The Group Recorded the Highest Ever Sales of HK$2.1B, Capture Opportunities Arising from National Policies to Foster Long Term Growth (in PDF)
2009-May-4	New Medicine Specializes in Treatment of Influenza Virus Type A Obtained Production Approval (in PDF)
2009-April-19	Market Launch of Acetaminophen and Dextromethorphan Hydrobromide Oral Solution - New Medicine Specializes in Treatment of Influenza and Cough (in PDF)
2009-April-8	The United Laboratories International Holdings Limited Announces 2008 Annual Results (in PDF)
2009-March-23	TUL's Products Acquired International Standard Accreditation Once Again Granted EU Certificate of Suitability (in PDF)
2024	2024 Press Releases
2023	2023 Press Releases
2022	2022 Press Releases
2021	2021 Press Releases
2020	2020 Press Releases
2019	2019 Press Releases
2018	2018 Press Releases
2017	2017 Press Releases
2016	2016 Press Releases
2015	2015 Press Releases
2014	2014 Press Releases
2013	2013 Press Releases
2012	2012 Press Releases
2011	2011 Press Releases
2010	2010 Press Releases
2008	2008 Press Releases
2007	2007 Press Releases